ALDX FY 2020 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALDXAldeyra Therapeutics, Inc.

$318M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$56,221

Operating Income

-$35M

Net Income

-$38M

EPS (Diluted)

$-1.11

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$83M

Total Liabilities

$24M

Stockholders' Equity

$60M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$56,221	-$96,305	+41.6%
Operating Income	-$35M	-$63M	+45.0%
Net Income	-$38M	-$61M	+38.3%